Literature DB >> 24166310

Identification of inhibitors of microRNA function from small molecule screens.

Colleen M Connelly1, Alexander Deiters.   

Abstract

Aberrant expression of microRNAs (miRNAs) has been linked to many human diseases including cancer, immune disorders, heart disease, and viral infections. Thus, small molecule inhibitors of miRNAs have potential as new therapeutic agents, as probes for the elucidation of detailed mechanisms of miRNA function, and as tools for the discovery of new targets for the treatment of human diseases. In order to identify small molecule inhibitors of specific miRNAs, functional assays have been developed and applied to the screening of small molecule libraries. Here, we report the application of a luciferase-based reporter assay of miRNA miR-122 function to the discovery of small molecule miR-122 inhibitors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24166310     DOI: 10.1007/978-1-62703-703-7_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

Review 1.  Small molecules with big roles in microRNA chemical biology and microRNA-targeted therapeutics.

Authors:  Rengen Fan; Chaocheng Xiao; Xinqiang Wan; Wenzhang Cha; Yufeng Miao; Yong Zhou; Chenglin Qin; Ting Cui; Fenglian Su; Xiangxiang Shan
Journal:  RNA Biol       Date:  2019-04-03       Impact factor: 4.652

Review 2.  An overview of microRNAs.

Authors:  Scott M Hammond
Journal:  Adv Drug Deliv Rev       Date:  2015-05-12       Impact factor: 15.470

Review 3.  MiRNA inhibition in tissue engineering and regenerative medicine.

Authors:  Kelsey R Beavers; Christopher E Nelson; Craig L Duvall
Journal:  Adv Drug Deliv Rev       Date:  2014-12-29       Impact factor: 15.470

4.  Cell-Based Reporter System for High-Throughput Screening of MicroRNA Pathway Inhibitors and Its Limitations.

Authors:  Katerina Brustikova; David Sedlak; Jana Kubikova; Ctibor Skuta; Katerina Solcova; Radek Malik; Petr Bartunek; Petr Svoboda
Journal:  Front Genet       Date:  2018-02-27       Impact factor: 4.599

Review 5.  Designing strategies of small-molecule compounds for modulating non-coding RNAs in cancer therapy.

Authors:  Rongyan Zhao; Jiahui Fu; Lingjuan Zhu; Yi Chen; Bo Liu
Journal:  J Hematol Oncol       Date:  2022-02-05       Impact factor: 17.388

Review 6.  Non-coding RNA in rhabdomyosarcoma progression and metastasis.

Authors:  Farah Ramadan; Raya Saab; Nader Hussein; Philippe Clézardin; Pascale A Cohen; Sandra E Ghayad
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.